Sihuan Pharmaceutical Gr... (SHPHF)

PNK: SHPHF · Real-Time Price · USD

0.12

-0.00 (-1.48%)

At close: Apr 30, 2025, 8:00 PM

Sihuan Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.89B	3.83B	5.68B	4.6B	5.12B	3.31B	831.86M	2.41B
Short-Term Investments	589.02M	962.99M	109.3M	332.68M	148.34M	1.3B	2.97B	1.71B
Long-Term Investments	1B	907.34M	972.53M	1.27B	1.26B	1.35B	1.05B	1.29B
Other Long-Term Assets	239.36M	-96.77M	-303.46M	-269.45M	-332.22M	-111.11M	-127.51M	-35.88M
Receivables	397.82M	522.25M	779.07M	389.82M	292.2M	476.74M	458.44M	591.19M
Inventory	557.32M	606.7M	715.3M	495.89M	409.6M	301.12M	227.97M	200.68M
Other Current Assets	31.24M	629.59M	455.36M	581.72M	337.87M	380.44M	288.7M	286.07M
Total Current Assets	6.2B	6.55B	7.74B	6.4B	6.31B	5.78B	4.77B	5.19B
Property-Plant & Equipment	2.84B	3B	4.09B	3.84B	3.62B	2.78B	2.45B	2.1B
Goodwill & Intangibles	657.37M	595.96M	459.97M	323.23M	285.23M	3.94B	3.8B	3.19B
Total Long-Term Assets	5.33B	4.5B	5.53B	5.43B	5.17B	8.07B	7.31B	6.59B
Total Assets	11.54B	12.14B	14.5B	13.04B	12.57B	15.44B	13.59B	12.19B
Account Payables	215.15M	205.78M	118.91M	106.2M	65.72M	37.2M	34.32M	82.66M
Deferred Revenue	1.68B	-340.26M	-205.19M	-393.37M	-4.06M	-59.42M	n/a	-8.28M
Short-Term Debt	287.26M	340.97M	200M	391.93M	n/a	n/a	180.75M	66.51M
Other Current Liabilities	1.4B	1.27B	1.1B	957.43M	982.28M	1.19B	948.77M	726.65M
Total Current Liabilities	4.11B	2.53B	2.5B	2.44B	2.26B	2.25B	1.9B	1.04B
Long-Term Debt	926.74M	848.67M	844.75M	359.17M	9M	95M	n/a	n/a
Other Long-Term Liabilities	1.33B	-45.86M	-31.46M	-585.88M	-718.92M	n/a	88.08M	1.00
Total Long-Term Liabilities	2.29B	848.67M	844.75M	359.17M	9M	95M	352.48M	178.02M
Total Liabilities	6.4B	6.5B	5.35B	3.1B	2.63B	2.67B	2.26B	1.22B
Total Debt	1.26B	1.19B	1.08B	755.05M	18.95M	95M	n/a	8.28M
Common Stock	77.06M	77.06M	77.06M	78.19M	78.19M	78.23M	78.23M	79.44M
Retained Earnings	1.34B	1.69B	4.92B	4.63B	5.57B	8.49B	7.01B	6.61B
Comprehensive Income	-1.22B	-913.86M	-597.15M	398.83M	-131.3M	-150.41M	-122.02M	-131.79M
Shareholders Equity	4.43B	4.74B	8.28B	9.19B	9.61B	12.51B	11.06B	10.9B
Total Investments	1B	1.87B	1.08B	1.6B	1.41B	2.65B	4.02B	3B